listing

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

THE WOODLANDS, TX, March 21, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical…

2 weeks ago
MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi RestakingMEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking

MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking

VICTORIA, Seychelles, March 20, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, announced the listing of Bedrock (BR) on both…

2 weeks ago
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…

3 weeks ago
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 07, 2025 16:05 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…

4 weeks ago
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 07, 2025 16:01 ET  | Source: Replimune Group Inc WOBURN, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…

4 weeks ago
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy OfficerAgios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

March 05, 2025 17:52 ET  | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals,…

4 weeks ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

March 04, 2025 16:05 ET  | Source: Definitive Healthcare Corp. FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare…

4 weeks ago
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 28, 2025 16:00 ET  | Source: Adverum Biotechnologies, Inc. REDWOOD CITY, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Adverum…

1 month ago
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 27, 2025 18:00 ET  | Source: Skye Bioscience, Inc. SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience,…

1 month ago
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 24, 2025 17:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…

1 month ago